M MDGL

Madrigal Pharmaceuticals Inc

$396.32

-8.08% ($34.84)

Volume 1.98M

52W High $615.00

52W Low $387.34

Market Cap $9.96B

Next Earnings Report

No earnings data available for MDGL

Last 10 quarters

Q2 2026 Jul 30, 2026

1-Day: -5.23%

5-Day: +2.93%

Q1 2026 May 12, 2026

1-Day: +1.69%

Q1 2026 May 6, 2026

1-Day: -0.90%

5-Day: -7.91%

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q4'25	$321.1M	+210.8%	92.4%	-18.6%	-$58.6M
Q3'25	$287.3M	+362.0%	93.7%	-39.7%	-$114.2M
Q2'25	$212.8M	+1,353.8%	95.7%	-22.2%	-$42.3M
Q1'25	$137.3M	+10,000.0%	96.7%	-57.8%	-$73.2M
Q4'24	$103.3M	+10,000.0%	96.7%	-64.8%	-$59.4M
Q3'24	$62.2M	+10,000.0%	96.5%	-187.1%	-$107.0M
Q2'24	$14.6M	+5,261.9%	95.7%	-1,110.4%	-$152.0M
Q4'23	$770,000	+670.0%	-18.4%	-10,000.0%	-$112.2M

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q3 2026	Nov 3, 2026	-$1.09	-$1.09	--	--	--
Q2 2026	Jul 30, 2026	-$2.55	-$2.55	-$1.99	+21.96%	Beat
Q1 2026	May 12, 2026	-$0.89	-$0.89	-$1.38	-55.00%	Missed
Q1 2026	May 6, 2026	-$4.14	-$4.14	-$1.38	+66.67%	Beat
Q1 2026	Apr 30, 2026	-$4.14	-$4.14	--	--	--
Q4 2025	Feb 19, 2026	-$0.60	-$0.88	-$2.57	--	Missed
Q3 2025	Nov 4, 2025	-$1.99	-$3.36	-$4.96	--	Missed
Q3 2025	Oct 29, 2025	-$3.36	-$3.36	-$4.96	-47.49%	Missed
Q2 2025	Aug 5, 2025	-$3.53	-$3.63	-$1.90	+46.18%	Beat
Q1 2025	May 5, 2025	-$6.28	-$6.28	-$3.32	+47.13%	Beat
Q1 2025	May 1, 2025	-$3.79	-$6.28	-$3.32	+12.40%	Beat
Q4 2024	Feb 26, 2025	-$4.12	-$4.13	-$2.71	+34.30%	Beat